Literature DB >> 10711554

Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis.

P Giraldo1, A von Nowaskonski, F A Gomes, I Linhares, N A Neves, S S Witkin.   

Abstract

OBJECTIVE: The asymptomatic carriage of Candida in the vagina of women with a history of recurrent vulvovaginal candidiasis was compared with that of women with no such history.
METHODS: Vaginal swabs from 50 women with a history of recurrent vulvovaginal candidiasis and 45 women with one or fewer episodes of candidal vaginitis within the past 12 months were evaluated for Candida by wet mount/Gram stain, culture, and polymerase chain reaction (PCR). All women were asymptomatic for at least 30 days.
RESULTS: Candida was identified in 28 women by PCR, in 14 women by culture, and in 13 women by wet mount/Gram stain. Candida was identified by PCR in a similar proportion of patients with previous recurrent vulvovaginal candidiasis (30%) and in controls (28.8%). However, Candida was identified by culture in more women with previous recurrent vulvovaginal candidiasis (22%) than in controls (6.6%, P = .04); it also was identified by wet mount/Gram stain in more women with recurrent vulvovaginal candidiasis (22%) than in controls (4.4%, P = .01). For the recurrent vulvovaginal candidiasis patients, culture and wet mount/Gram stain had a sensitivity of 66.6% compared with PCR. For the controls, the sensitivity of the two former assays relative to PCR was only 15.3%.
CONCLUSION: Women with a history of recurrent vulvovaginal candidiasis have more easily detectable Candida in their vagina, even when asymptomatic, than do other women. A relative inefficiency in regulating the proliferation of Candida in the vagina may increase susceptibility to periodic symptomatic recurrences.

Entities:  

Mesh:

Year:  2000        PMID: 10711554     DOI: 10.1016/s0029-7844(99)00577-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

1.  Vulvovaginal candidiasis.

Authors:  D J White; A Vanthuyne
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

2.  The Role of PCR in the Diagnosis of Candida Vulvovaginitis-a New Gold Standard?

Authors:  J D Sobel; Robert A Akins
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

3.  Group B streptococcus: prevalence in a non-obstetric population.

Authors:  Catherine M Leclair; Ashley E Hart; Martha F Goetsch; Heather Carpentier; Jeffrey T Jensen
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

4.  Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Dorota Piekna-Przybylska; Sanjay B Maggirwar; Constantine G Haidaris; Richard P Phipps
Journal:  J Low Genit Tract Dis       Date:  2018-01       Impact factor: 1.925

5.  Identification of novel mechanisms involved in generating localized vulvodynia pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Christopher J Stodgell; Richard P Phipps
Journal:  Am J Obstet Gynecol       Date:  2015-02-12       Impact factor: 8.661

6.  Association between atopy and recurrent vaginal candidiasis.

Authors:  N A Neves; L P Carvalho; M A M De Oliveira; P C Giraldo; O Bacellar; A A Cruz; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

7.  Pathogenesis of Recurrent Vulvovaginal Candidiasis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

8.  Patterns of Expression of Vaginal T-Cell Activation Markers during Estrogen-Maintained Vaginal Candidiasis.

Authors:  Ameera Al-Sadeq; Mawieh Hamad; Khaled Abu-Elteen
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

9.  Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia.

Authors:  A Brian Mochon; Ye Jin; Jin Ye; Matthew A Kayala; John R Wingard; Cornelius J Clancy; M Hong Nguyen; Philip Felgner; Pierre Baldi; Haoping Liu
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

10.  Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.

Authors:  D J White; A Vanthuyne; P M Wood; J G Ayres
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.